<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54-vaccines-08-00468">
 <label>54.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tuyaerts</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rombauts</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Everaert</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Van Nuffel</surname>
    <given-names>A.M.T.</given-names>
   </name>
   <name>
    <surname>Amant</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer</article-title>
  <source>Front. Nutr.</source>
  <year>2019</year>
  <volume>5</volume>
  <fpage>138</fpage>
  <pub-id pub-id-type="doi">10.3389/fnut.2018.00138</pub-id>
  <?supplied-pmid 30687714?>
  <pub-id pub-id-type="pmid">30687714</pub-id>
 </element-citation>
</ref>
